Dr. S. Karthik, the founder of Biovista, is a scientific professional with research and mentorship experiences in the private, public & military-defense sectors equipped with strong intellectual property creation. Dr. Karthik earned his PhD and post-doctoral studies in Molecular Microbiology from Michigan State University and Bayer Corporation USA etc., with research focused on virulence regulation, microbial pathogenesis and developing novel small molecules for addressing bacterial infections. Furthermore, he conducted cutting edge military research as a scientist at the Walter Reed Army Institute of Research, a prestigious research institute of the United States Military in Washington, D.C. USA. He had successfully executed studies for the congressionally directed Defense Medical Research Development and Military Infectious Disease Research Programs. He held leadership positions at Colgate-Palmolive, USA, spearheading research and development programs on emerging technologies in advancing oral care therapeutics. More recently, he was leading the open innovation platform at L'Oreal USA creating strategic partnerships & technology transfers to foster disruptive science based programs on next generation skin disease therapies. In addition to this, he had been networking at international conferences allowing him to stay abreast on current technologies to help advance research programs.
A scientific professional with over 20 years of academic, government and corporate experiences in the USA, he has published research articles in reputed journals and holds several intellectual properties and patents as well. He has served as a peer reviewer for scientific journals and consulted start up ventures etc. During his career, he has managed teams, coached, mentored several students and scientists aiding towards their career progression. To his credit, he held the highly competitive and the prestigious NRC fellowship from the National academy of Sciences, USA. Furthermore, he has completed leadership & public speaking training from the globally reputed Dale Carnegie etc.
Dr. Paul Stoodley serves as Biovista’s scientific advisory board member. Dr. Stoodley is a Professor of Microbial Infection and Immunity at the Ohio State University College of Medicine, USA and Microbial Tribology at the University of Southampton, UK. Dr. Stoodley received his PhD in Biological Sciences from Exeter University and did his postdoctoral training with Dr. Bill Costerton at the Center for Biofilm Engineering in Bozeman, Montana State University. Previously, he held the posts of Associate Professor of Immunology and Microbiology and Vice-Director of Imaging at the Center for Genomic Sciences (CGS) Pittsburgh, USA. Dr. Stoodley serves as a consultant for BioSurface Technologies, Valam Inc, Semprus Biosciences and Philips Oral Healthcare, where he also serves on the scientific advisory board. He conducts reviewing and editorial duties for various peer-reviewed journals and has also organized the American Society of Microbiology “Biofilms” conference series. He was awarded the Hanse-Wissenschaftskolleg (HWK) fellowship for collaborative research at the Max Planck Institute for Marine Microbiology, Bremen, Germany. Dr. Stoodley has published over 200 articles including reviews, research papers and book chapters. He has mentored numerous undergraduates as well as MS, PhD, visiting scientists and post-doctoral scholars.
Dr. Stoodley’s research interest includes 1. Influence of genetic and environmental factors on biofilm development and dynamic behavior. 2. Mechanical strength of biofilms and removal strategies. 3. Biofilm monitoring and control in medicine, industry and natural environments. 4. Development of antibiofilm materials and coatings. Dr. Stoodley’s vast experience shall contribute to constantly fuel the knowledge pipeline of Biovista.
Harsh Trivedi is another highly valuable member on the Biovista’s scientific advisory board. Harsh is a scientist, teacher and mentor with 25 years experience in a fast-moving consumer goods company. Harsh obtained both his MS and MBA from Rutgers University. After a brief stint at Johnson and Johnson, he progressed in his career to hold various R&D leadership positions at Colgate-Palmolive. He has expertise across broad range of subjects from natural therapeutics, inflammation modulation, formulation chemistry and host modulation. He held various leadership and senior management positions having headed research and development efforts in host modulation, new methods at Colgate-Palmolive. He has authored several research articles and has over 45 issued US and worldwide patents. Most recently, he was part of a team that led to the first oral care company to send an experiment to the International Space Station in 2021.